Mobile health platform for managing medications and drug labeling
Evaluating the Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe): a Cluster Randomized Trial
NA · Seoul National University · NCT06703697
This study tests if a new mobile app for managing medications can help adults who take multiple drugs stick to their treatment plans better than using paper methods.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 360 (estimated) |
| Ages | 18 Years to 79 Years |
| Sex | All |
| Sponsor | Seoul National University (other) |
| Locations | 1 site (Seoul, Gwanak-gu) |
| Trial ID | NCT06703697 on ClinicalTrials.gov |
What this trial studies
This cluster randomized trial aims to evaluate the effectiveness of eDrugSafe, a mobile web platform designed for electronic labeling and medication management, in improving medication adherence and self-efficacy among adults taking multiple medications. The study will compare the outcomes of participants using eDrugSafe with those receiving traditional paper methods of medication management. Additionally, it will assess the feasibility and acceptability of implementing eDrugSafe in community pharmacies. The primary focus is on enhancing the quality of life and reducing hospitalizations for participants.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 79 who speak Korean and are taking three or more medications.
Not a fit: Patients who are not taking multiple medications or who do not consent to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could significantly improve medication adherence and self-management for patients on multiple medications.
How similar studies have performed: Other studies have shown promise in using mobile health platforms for medication management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 to 79 years. 2. Individuals who can speak and understand Korean. 3. Possession of a personal electronic device capable of accessing mobile applications and web services over wireless internet (bring participants' own device, BYOD). 4. Patients taking three or more medications with at least one medication prescribed for 28 days or longer. 5. Individuals who have provided direct consent to participate in the study. Exclusion Criteria: 1. Individuals using any mobile web platform other than eDrugSafe for medication safety information purposes after enrollment. 2. Individuals who do not consent to participate in the study or who withdraw their consent.
Where this trial is running
Seoul, Gwanak-gu
- Seoul National University — Seoul, Gwanak-gu, South Korea (RECRUITING)
Study contacts
- Study coordinator: Jung-Mi Oh, Pharm.D
- Email: jmoh@snu.ac.kr
- Phone: +82 10 4880 5699
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Mobile Health, Medication Management, Drug Labelling, Drug E-label, electronic labeling, hybrid study, implementation, cluster randomized trial